Spinraza remains a big product for Biogen, but has seen its sales go into reverse as competition in SMA treatment has emerged ...

Nusinersen (Spinraza) (used to treat both adults and children), and Risdiplam (Evrysdi) is a small molecule which is also used to treat both adults and children. However, the cost of these ...

Nusinersen (Spinraza) is an injection, which can be used to treat both adults and children, and risdiplam (Evrysdi), which is a small molecule also used to treat both adults and children. He said that ...

Biogen’s applications for the higher dose regimen of SMA drug Spinraza are now under review in the US and Europe.

The parents of two-year-old Aakriti Singh diagnosed with Spinal Muscular Atrophy – SMA type-1, are worried about her next ...

Detailed results from the phase 3 SAPPHIRE trial, which involves patients with non-ambulatory type 2/3 SMA treated with Spinraza (nusinersen) or Evrysdi (risdiplam), are expected to be presented ...

All but two patients in the study had been diagnosed with SMA type 1. When combined with a therapy like Spinraza, low-dose risdiplam — the active ingredient in Evrysdi, an approved disease-modifying ...

Existing disease-modifying SMA therapies — Spinraza, Evrysdi (risdiplam), and the gene therapy Zolgensma (onasemnogene abeparvovec-xioi) — can provide significant motor and respiratory benefits to ...